Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa

Haemophilia and its treatment interfere with patients' life, so health-related quality of life (HRQoL) should be assessed when evaluating treatments. This study investigated the HRQoL of patients with haemophilia A treated prophylactically with a new recombinant factor VIII. Two phase 3 trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Santagostino, E, Lentz, S R, Busk, A K, Regnault, A, Iorio, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282346/
https://www.ncbi.nlm.nih.gov/pubmed/24471912
http://dx.doi.org/10.1111/hae.12371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282346/
https://www.ncbi.nlm.nih.gov/pubmed/24471912
http://dx.doi.org/10.1111/hae.12371

Ejemplares similares